NCT07656623招募中不适用
The Effects of the Multispecies Probiotic Mixture Ecologic Barrier for Patients With Irritable Bowel Syndrome With Upper Gastrointestinal Symptoms and Having Anxiety, Depression, and Stress Symptoms
Institute of Gastroenterology and Hepatology, Vietnam1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年6月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 60
- 试验地点
- 1
研究概览
简要总结
The aim of this clinical trial is to find out whether Ecologic Barrier is effective in supporting the treatment of irritable bowel syndrome (IBS) in adults. The main questions that this trial aims to answer are:
- Does Ecologic Barrier help improve IBS severity when added to standard IBS treatment?
- Does Ecologic Barrier help improve symptoms of anxiety, depression, and stress in patients with IBS?
- Does Ecologic Barrier help improve upper gastrointestinal symptoms when added to standard IBS treatment?
- What adverse events may occur when using Ecologic Barrier? The researchers will compare a group receiving standard symptom-based treatment with another group receiving standard treatment plus Ecologic Barrier.
Participants will:
- Receive IBS treatment for 2 months, with Ecologic Barrier added during either the first month or the second month, depending on random assignment.
- Attend a follow-up visit after 1 month of treatment.
- Take part in interviews about IBS severity, symptom improvement, adverse events, and symptoms of depression and anxiety at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Supportive Care
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Indication for upper endoscopy and colonoscopy;
- •Diagnosed with IBS-D according to Rome IV criteria;
- •Presence of at least one upper gastrointestinal symptom, including: retrosternal burning, reflux, epigastric pain, epigastric burning, postprandial discomfort, early satiety, abdominal bloating, belching, sour regurgitation, nausea/vomiting;
- •Manifestations of anxiety, depression, or stress, with at least one of the three DASS-21 subscale scores exceeding the normal threshold (depression score >9 and/or anxiety score >7 and/or stress score >14).
排除标准
- •Positive for Helicobacter pylori by rapid urease test during endoscopy or by 13C-urea breath test;
- •Currently using anxiolytic or antidepressant medication;
- •Currently or previously used antibiotics within the past month;
- •Currently or previously used symptomatic treatment, probiotics, or proton pump inhibitors (PPI) within the past two weeks;
- •History of gastrointestinal surgery;
- •Endoscopic findings of organic lesions: ulcer, acute inflammation, colonic polyp >5 mm, or colonic polyp <5 mm with suspected neoplasia;
- •Pregnant or breastfeeding women.
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
Phase 3 4
A Study of Probiotic Therapy Along with Antibiotics for Treating and Preventing Recurrence of Bacterial Vaginosis in WomenCTRI/2026/01/100576SRM Medical College Hospital And Research Centre60
尚未招募
不适用
Study on the Benefits of Probiotics in Patients Undergoing Colorectal SurgeryCTRI/2025/12/099932Anugrah Memorial College Gaya88
尚未招募
2 期
Can Probiotics Help Control Blood Sugar in Type 2 DiabetesCTRI/2025/08/093165Self50
尚未招募
不适用
Probiotics in Functional DyspepsiaFunctional DyspepsiaNCT07276009Nordic Biotic Sp. z o.o.60
已完成
不适用
Probiotic Intervention for People With Multiple SclerosisMultiple SclerosisNCT07304713Sheffield Hallam University29